Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-24

Clinical Trial Update: Treatment of Tinnitus With Olanzapine [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated olanzapine for the treatment of tinnitus and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Tinnitus, Tinnitus, Subjective | Phase 1 | Status: COMPLETED